SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-043660
Filing Date
2021-03-30
Accepted
2021-03-30 08:00:15
Documents
5
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212490-1_def14a.htm DEF 14A 639920
2 GRAPHIC lg_rubiustherapeut-4c.jpg GRAPHIC 68699
3 GRAPHIC sg_pablocagnoni-bw.jpg GRAPHIC 6899
4 GRAPHIC tm212490d1-proxy_rubius1bw.jpg GRAPHIC 486299
5 GRAPHIC tm212490d1-proxy_rubius2bw.jpg GRAPHIC 530565
  Complete submission text file 0001104659-21-043660.txt   2146066
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38586 | Film No.: 21783682
SIC: 2836 Biological Products, (No Diagnostic Substances)